Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2004 | 03-2004 | 09-2003 | 06-2003 | |
| Sales | 1,016 | 924 | 1,675 | 2,281 |
| Gross Profit | 1,016 | 924 | 1,675 | 2,281 |
| Operating Expenses | 6,901 | 7,356 | 4,990 | 5,185 |
| Operating Income | -5,885 | -6,432 | -3,316 | -2,904 |
| Interest Expense | 119 | 136 | 163 | 185 |
| Other Income | 117 | 87 | 102 | 112 |
| Pre-tax Income | -5,887 | -6,481 | -3,376 | -2,977 |
| Net Income Continuous | -5,887 | -6,481 | -3,376 | -2,977 |
| Net Income | $-5,887 | $-6,481 | $-3,376 | $-2,977 |
| EPS Basic Total Ops | -0.42 | -0.58 | -0.30 | -0.26 |
| EPS Basic Continuous Ops | -0.90 | -4.34 | -2.31 | -2.04 |
| EPS Diluted Total Ops | -0.42 | -0.58 | -0.30 | -0.26 |
| EPS Diluted Continuous Ops | -0.90 | -4.34 | -2.31 | -2.04 |
| EBITDA(a) | $-5,577 | $-6,097 | $-2,976 | $-2,904 |